Replies to post #22421 on $heff's $tation of $tocks & $olid DD

[$heff]

w/PARD ($2.13-nasdaq) you have the 2010 ASCO GI Symposium on Saturday (Jan 24th) where they will be presenting Phase II data in CRC.

http://www.asco.org/ASCOv2/Meetings/Gastrointestinal+Cancers+Symposium

[$heff]

elcheepo...w/ PARD ($2.13-nasdaq) you have the 2010 ASCO GI Symposium on Saturday (Jan 24th) where they will be presenting Phase II data in CRC. This data is very pivotal in the fate of the company. I will discuss tomorrow & outline why this is an important event for the company! I just picked this up today and am surprised no one else has discussed this. A solid forward-looking event. $heff

http://www.asco.org/ASCOv2/Meetings/Gastrointestinal+Cancers+Symposium






Message in reply to:

Hi Sheff... what do you see with PARD as far as a forward looking event?